Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-12-033004
Filing Date
2012-05-04
Accepted
2012-05-04 11:23:21
Documents
11
Period of Report
2012-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q a12-6655_110q.htm 10-Q 716737
2 EX-31.1 a12-6655_1ex31d1.htm EX-31.1 14335
3 EX-31.2 a12-6655_1ex31d2.htm EX-31.2 14244
4 EX-32.1 a12-6655_1ex32d1.htm EX-32.1 7960
5 EX-32.2 a12-6655_1ex32d2.htm EX-32.2 10529
  Complete submission text file 0001104659-12-033004.txt   6516839

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT cvd-20120331.xml EX-101.INS 630134
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cvd-20120331.xsd EX-101.SCH 74528
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT cvd-20120331_cal.xml EX-101.CAL 54241
9 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT cvd-20120331_lab.xml EX-101.LAB 1379720
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cvd-20120331_pre.xml EX-101.PRE 626481
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT cvd-20120331_def.xml EX-101.DEF 440334
Mailing Address COVANCE INC 210 CARNEGIE CENTER PRINCETON NJ 08540
Business Address 210 CARNEGIE CENTER PRINCETON NJ 08540 6094524440
COVANCE INC (Filer) CIK: 0001023131 (see all company filings)

EIN.: 223265977 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-12213 | Film No.: 12812620
SIC: 8731 Services-Commercial Physical & Biological Research